Pharmacoeconomic studies of asthma controller drugs: marketing gimmick or icing on the cake?
Hendeles
Leslie
L
Segal
Richard
R
D000085:Acetates / Q000191:economics / Q000627:therapeutic use; D000280:Administration, Inhalation; D000284:Administration, Oral; D000730:Androstadienes / Q000191:economics / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000191:economics / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000191:economics*; D015331:Cohort Studies; D003521:Cyclopropanes; D017850:Economics, Pharmaceutical; D000068298:Fluticasone; D006801:Humans; D007211:Indoles; D020024:Leukotriene Antagonists / Q000191:economics / Q000627:therapeutic use; D008329:Managed Care Programs / Q000191:economics; D008389:Marketing of Health Services / Q000191:economics*; D048448:Phenylcarbamates; D011804:Quinolines / Q000191:economics / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013440:Sulfides; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000191:economics / Q000627:therapeutic use
D000085:Acetates; D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D003521:Cyclopropanes; D007211:Indoles; D020024:Leukotriene Antagonists; D048448:Phenylcarbamates; D011804:Quinolines; D013440:Sulfides; D013449:Sulfonamides; D014105:Tosyl Compounds; D000068298:Fluticasone; C093875:montelukast; C062735:zafirlukast